doi: 10.1089/dna.2021.0465 166 FalusAGiliczeA
Finally, the combination of novel drug therapies, a better understanding of the -synuclein clearance by astrocytes, the use of neurotoxic models, growth factors use and other therapies that increase astrocyte survival and its antioxidant function may shed light on a prospective cure of PD in the near future
[6] [7] Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid, binding more strongly to both the high and low-affinity binding sites of plasminogen
BPC157, Body Protective Compound 157, Pentadecapeptide BPC-157, BPC 157
This hydrates, provides antioxidants, and supports liver detox
Beskyttes mot direkte lys og fuktighet for optimal holdbarhet